Court Lifts Order Barring Teva’s Generic Lotrel

Law360, New York (May 21, 2007, 12:00 AM EDT) -- After encountering a roadblock in its long-running patent feud with Novartis AG, Teva Pharmaceutical Industries Ltd. said late Monday that a federal district court had vacated a temporary restraining order it had issued on Saturday that barred the Israeli generics maker from shipping a generic version of the drug.

The order, entered on Saturday in the U.S. District Court for the District of New Jersey, granted Novartis’ emergency request for a temporary order barring Teva's launch of its generic Lotrel product in connection with the Swiss...
To view the full article, register now.